Skip to main content
2024 CRT Conference Main banner
Back

CRT 2024

Best Abstracts Monday

The Preclinical Efficacy And Safety Of SA016, A Small Interfering RNA (siRNA) Therapeutic Agent In Hypertension

Monday, March 11, 2024
2:00 PM – 2:08 PM ET

    Speaker(s)

  • Zhiwei Yang, PhD

    Founder and CEO
    Suzhou Siran Biotechnology, Co. Ltd.
    San Diego, California, United States

    No relationships to disclose